Challacombe S J, Rahman D, Jeffery H, Davis S S, O'Hagan D T
Department of Oral Medicine, UMDS, Guy's Hospital, London, U.K.
Immunology. 1992 May;76(1):164-8.
Intragastric immunization may lead to the induction of antibodies in the secretory immune system including saliva. The antibody response is usually short-lived. The objectives of this study were to see whether oral immunization with biodegradable microparticles containing antigen might lead to enhanced mucosal responses. Ovalbumin (OVA) was entrapped in a novel antigen delivery system comprising poly (D,L-lactide-co-glycolide) (PLGA) microparticles. Salivary IgA and serum IgG responses after three daily oral immunizations in BALB/c mice were assayed by ELISA at weekly intervals and compared with those to soluble antigen. Low levels of salivary IgA antibodies were detected at Weeks 2 and 3 in both groups and no significant differences were found. After a secondary series of intragastric immunizations at Week 4, marked differences were apparent between the groups. The mean salivary IgA titre at Week 6 was 959 +/- 494 U compared with 30 +/- 5 in the soluble OVA group (P less than 0.0001). Significant differences were still apparent at Weeks 7-8 through the value was falling. Serum IgG antibodies were detectable and were significantly greater in the particle group (at Weeks 4 and 8) than in controls (P less than 0.001). These results suggest that microparticles are taken up by antigen-presenting cells in Peyer's patches, then slowly degrade in vivo and release entrapped antigens, and thus can function as potent antigen delivery systems giving rise to both mucosal and systemic responses. Microparticles have considerable potential as a controlled released antigen delivery system for the induction of longer-term immune responses at mucosal surfaces.
胃内免疫可能会在包括唾液在内的分泌免疫系统中诱导抗体产生。抗体反应通常是短暂的。本研究的目的是观察用含有抗原的可生物降解微粒进行口服免疫是否会增强黏膜反应。卵清蛋白(OVA)被包裹在一种新型抗原递送系统中,该系统由聚(D,L-丙交酯-共-乙交酯)(PLGA)微粒组成。通过ELISA每周检测BALB/c小鼠每日口服免疫三次后的唾液IgA和血清IgG反应,并与可溶性抗原组的反应进行比较。两组在第2周和第3周均检测到低水平的唾液IgA抗体,未发现显著差异。在第4周进行第二轮胃内免疫后,两组之间出现了明显差异。第6周时,微粒组的唾液IgA平均滴度为959±494 U,而可溶性OVA组为30±5(P<0.0001)。在第7 - 8周,差异仍然显著,尽管数值在下降。血清IgG抗体可被检测到,微粒组(在第4周和第8周)的血清IgG抗体明显高于对照组(P<0.001)。这些结果表明,微粒被派尔集合淋巴结中的抗原呈递细胞摄取,然后在体内缓慢降解并释放包裹的抗原,因此可以作为有效的抗原递送系统,引发黏膜和全身反应。微粒作为一种可控释放的抗原递送系统,在诱导黏膜表面长期免疫反应方面具有相当大 的潜力。